Noubar Afeyan - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Noubar Afeyan has filed 2 SEC Form 4 filings across 1 company in the last 90 days - active on both sides. Lifetime open-market purchases: $75.00M. Lifetime open-market sales: $434K. Historical track record: 5/5 stars across 3 tracked purchases.
Profile
Noubar Afeyan is a corporate insider at Moderna, Inc. (MRNA). Afeyan has also held reporting roles at Generate Biomedicines, Inc. (GENB). Afeyan has reported 5 insider filings with the SEC since 2025. The most recent filing was in May 2026.
| Role | Insider |
|---|---|
| Notability | 45/100 |
| Links | Wikipedia |
Board memberships
- Moderna, Inc.
- Generate Biomedicines, Inc.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +0.00% |
| Avg 30-day return | +9.37% |
| Avg 90-day return | +6.57% |
| Best 30-day return | +9.37% |
Trading Pattern
InsiderAlpha's records for Noubar Afeyan go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $25.00M (3 buys totaling $75.00M). The largest single buy on record is $25.00M of GENB in 2026. Sales side: 1 recorded sale totaling $434K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Noubar Afeyan has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at Moderna, Inc. (MRNA) - 1 filing, 2026
- Director at Moderna, Inc. (MRNA) - 2 filings, 2025 to 2026
- Insider at Generate Biomedicines, Inc. (GENB) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | MRNA | Moderna, Inc. | S - Open-market sale | 9.3K | $46.84 | $434K |
| 2026-05-22 | MRNA | Moderna, Inc. | M - Option exercise | 9.3K | $19.15 | $177K |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | P - Open-market purchase | 1.56M | $16.00 | $25.00M |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | P - Open-market purchase | 1.56M | $16.00 | $25.00M |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | P - Open-market purchase | 1.56M | $16.00 | $25.00M |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | J - Other acquisition / disposition | 2.78M | - | |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | J - Other acquisition / disposition | 2.78M | - | |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | J - Other acquisition / disposition | 987.5K | - | |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | J - Other acquisition / disposition | 13.70M | - | |
| 2026-03-02 | GENB | Generate Biomedicines, Inc. | J - Other acquisition / disposition | 12.72M | - |
Companies - Last 90 Days
- Moderna, Inc. (MRNA) - 2 filings, last 2026-05-22
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Noubar Afeyan has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Stephen Hoge - $16.74M of MRNA open-market activity in the last 12 months
- Shannon Thyme Klinger - $900K of MRNA open-market activity in the last 12 months
- Abbas Hussain - $265K of MRNA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Novo Holdings A/S
- William O'Dowd IV
- Eric L. Oliver
- Opaleye Management Inc.
- ORBIMED ADVISORS LLC
- Stephen G. Pagliuca
- Pale Fire Capital SE
- Bhaskar Panigrahi
Frequently Asked Questions
Who is Noubar Afeyan?
Noubar Afeyan is a corporate insider at Moderna, Inc. (MRNA). Afeyan has also held reporting roles at Generate Biomedicines, Inc. (GENB). Afeyan has reported 5 insider filings with the SEC since 2025. The most recent filing was in May 2026.…
How many SEC Form 4 filings has Noubar Afeyan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Noubar Afeyan been buying or selling stock?
Recorded transactions: 3 open-market purchases ($75.00M) and 1 open-market sale ($434K) across all tracked filings.
How accurate is Noubar Afeyan's historical track record?
Across 3 tracked purchases, Noubar Afeyan averaged +9.4% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Noubar Afeyan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Noubar Afeyan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.